1036 related articles for article (PubMed ID: 19747641)
21. Longitudinal assessment of hematopoietic abnormalities after autologous hematopoietic cell transplantation for lymphoma.
Bhatia R; Van Heijzen K; Palmer A; Komiya A; Slovak ML; Chang KL; Fung H; Krishnan A; Molina A; Nademanee A; O'Donnell M; Popplewell L; Rodriguez R; Forman SJ; Bhatia S
J Clin Oncol; 2005 Sep; 23(27):6699-711. PubMed ID: 16170178
[TBL] [Abstract][Full Text] [Related]
22. Differential prognostic impact of pretransplant comorbidity on transplant outcomes by disease status and time from transplant: a single Japanese transplant centre study.
Kataoka K; Nannya Y; Ueda K; Kumano K; Takahashi T; Kurokawa M
Bone Marrow Transplant; 2010 Mar; 45(3):513-20. PubMed ID: 19684632
[TBL] [Abstract][Full Text] [Related]
23. Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program.
Karanes C; Nelson GO; Chitphakdithai P; Agura E; Ballen KK; Bolan CD; Porter DL; Uberti JP; King RJ; Confer DL
Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):8-15. PubMed ID: 18721775
[TBL] [Abstract][Full Text] [Related]
24. Identical outcome after autologous or allogeneic genoidentical hematopoietic stem-cell transplantation in first remission of acute myelocytic leukemia carrying inversion 16 or t(8;21): a retrospective study from the European Cooperative Group for Blood and Marrow Transplantation.
Gorin NC; Labopin M; Frassoni F; Milpied N; Attal M; Blaise D; Meloni G; Iori AP; Michallet M; Willemze R; Deconninck E; Harousseau JL; Polge E; Rocha V
J Clin Oncol; 2008 Jul; 26(19):3183-8. PubMed ID: 18506024
[TBL] [Abstract][Full Text] [Related]
25. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.
Majhail NS; Mothukuri JM; Brunstein CG; Weisdorf DJ
Biol Blood Marrow Transplant; 2009 May; 15(5):564-73. PubMed ID: 19361748
[TBL] [Abstract][Full Text] [Related]
26. Long-term outcome of allogeneic or autologous haemopoietic cell transplantation for acute lymphoblastic leukaemia in second remission in children. GETMON experience 1983-1998.
Badell I; Muñoz A; Ortega JJ; Martínez A; Madero L; Bureo E; Verdeguer A; Fernandez-Delgado R; Cubells J; Soledad-Maldonado M; Olivé T; Sastre A; Baro J; Díaz MA;
Bone Marrow Transplant; 2005 May; 35(9):895-901. PubMed ID: 15778727
[TBL] [Abstract][Full Text] [Related]
27. Outcomes of 5-year survivors of pediatric liver transplantation: report on 461 children from a north american multicenter registry.
Ng VL; Fecteau A; Shepherd R; Magee J; Bucuvalas J; Alonso E; McDiarmid S; Cohen G; Anand R;
Pediatrics; 2008 Dec; 122(6):e1128-35. PubMed ID: 19047213
[TBL] [Abstract][Full Text] [Related]
28. Reduced intensity conditioning (RIC) haematopoietic cell transplants in elderly patients with AML.
Niederwieser D; Lange T; Cross M; Basara N; Al-Ali H
Best Pract Res Clin Haematol; 2006; 19(4):825-38. PubMed ID: 16997186
[TBL] [Abstract][Full Text] [Related]
29. Imatinib use either pre- or post-allogeneic hematopoietic cell transplantation (allo-HCT) does not increase cardiac toxicity in chronic myelogenous leukemia patients.
Burke MJ; Trotz B; Luo X; Weisdorf DJ; Baker KS; Wagner JE; Verneris MR
Bone Marrow Transplant; 2009 Aug; 44(3):169-74. PubMed ID: 19204709
[TBL] [Abstract][Full Text] [Related]
30. Late Mortality and Causes of Death among Long-Term Survivors after Allogeneic Stem Cell Transplantation.
Atsuta Y; Hirakawa A; Nakasone H; Kurosawa S; Oshima K; Sakai R; Ohashi K; Takahashi S; Mori T; Ozawa Y; Fukuda T; Kanamori H; Morishima Y; Kato K; Yabe H; Sakamaki H; Taniguchi S; Yamashita T;
Biol Blood Marrow Transplant; 2016 Sep; 22(9):1702-1709. PubMed ID: 27246369
[TBL] [Abstract][Full Text] [Related]
31. Posttransplant thrombopoiesis predicts survival in patients undergoing autologous hematopoietic progenitor cell transplantation.
Ninan MJ; Flowers CR; Roback JD; Arellano ML; Waller EK
Biol Blood Marrow Transplant; 2007 Aug; 13(8):895-904. PubMed ID: 17640593
[TBL] [Abstract][Full Text] [Related]
32. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.
Tichelli A; Passweg J; Wójcik D; Rovó A; Harousseau JL; Masszi T; Zander A; Békássy A; Crawley C; Arat M; Sica S; Lutz P; Socié G;
Haematologica; 2008 Aug; 93(8):1203-10. PubMed ID: 18556401
[TBL] [Abstract][Full Text] [Related]
33. Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls.
Syrjala KL; Langer SL; Abrams JR; Storer BE; Martin PJ
J Clin Oncol; 2005 Sep; 23(27):6596-606. PubMed ID: 16170167
[TBL] [Abstract][Full Text] [Related]
34. Bone marrow transplant in myelodysplastic syndromes: new technologies, same questions.
Giralt S
Curr Hematol Rep; 2005 May; 4(3):200-7. PubMed ID: 15865872
[TBL] [Abstract][Full Text] [Related]
35. [Usefulness of hematopoietic cell transplantation-specific comorbidity index after allogeneic hematopoietic stem cell transplantation].
Fujimaki K; Sakai R; Fujisawa S; Fujita H; Tanaka M; Hagihara M; Koharazawa H; Miyazaki T; Tomita N; Kanamori H; Maruta A; Ishigatsubo Y
Gan To Kagaku Ryoho; 2008 Jan; 35(1):87-91. PubMed ID: 18195534
[TBL] [Abstract][Full Text] [Related]
36. The evolution of hematopoietic SCT in myelodysplastic syndrome.
Kindwall-Keller T; Isola LM
Bone Marrow Transplant; 2009 Apr; 43(8):597-609. PubMed ID: 19252532
[TBL] [Abstract][Full Text] [Related]
37. Partially matched related hematopoietic stem cell transplantation without ex vivo T cell depletion compared with matched unrelated transplantation in adult patients with hematologic malignancies.
Wang Y; Chen F; Han Y; Fu ZZ; Tang XW; Miao M; Qiu HY; Jin ZM; Sun AN; Wu DP
Biol Blood Marrow Transplant; 2009 Oct; 15(10):1258-64. PubMed ID: 19747633
[TBL] [Abstract][Full Text] [Related]
38. Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study.
Bhatia S; Robison LL; Francisco L; Carter A; Liu Y; Grant M; Baker KS; Fung H; Gurney JG; McGlave PB; Nademanee A; Ramsay NK; Stein A; Weisdorf DJ; Forman SJ
Blood; 2005 Jun; 105(11):4215-22. PubMed ID: 15701723
[TBL] [Abstract][Full Text] [Related]
39. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
[TBL] [Abstract][Full Text] [Related]
40. Second allogeneic hematopoietic stem cell transplantation in hematologic malignancies in children: long-term results of a multicenter study of the Spanish Working Party for Bone Marrow Transplantation in Children (GETMON).
Muñoz A; Badell I; Olivé T; Verdeguer A; Gómez P; Bureo E;
Haematologica; 2002 Mar; 87(3):331-2. PubMed ID: 11869952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
